Silencing p75NTR prevents proNGF-induced endothelial cell death and development of acellular capillaries in rat retina

Molecular Therapy Methods and Clinical Development

Volumn 2, Issue , 2015, Pages 15013-

  Shanab, Ahmed Y ^a,b,c   Mysona, Barbara A ^a,b,c   Matragoon, Suraporn ^a,b,c   El Remessy, Azza B ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAPILLARY; CELL DEATH; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; RETINA BLOOD VESSEL; RETINA CELL; RETINA ISCHEMIA; ANIMAL EXPERIMENT; GENE OVEREXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINA CAPILLARY; WESTERN BLOTTING;

EID: 85015186265     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2015.13     Document Type: Article

References (48)

1. 1 Mysona, BA, Shanab, AY, Elshaer, SL, El-Remessy, AB, Nerve growth factor in diabetic retinopathy: beyond neurons. Expert Rev Ophthalmol 9 (2014), 99–107.
2. 2 Osborne, NN, Casson, RJ, Wood, JP, Chidlow, G, Graham, M, Melena, J, Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 23 (2004), 91–147.
3. 3 von Bartheld, CS, Neurotrophins in the developing and regenerating visual system. Histol Histopathol 13 (1998), 437–459.
4. 4 Huang, EJ, Reichardt, LF, Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24 (2001), 677–736.
5. 5 Steinle, JJ, Granger, HJ, Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation. Auton Neurosci 108 (2003), 57–62.
6. 6 Jadhao, CS, Bhatwadekar, AD, Jiang, Y, Boulton, ME, Steinle, JJ, Grant, MB, Nerve growth factor promotes endothelial progenitor cell-mediated angiogenic responses. Invest Ophthalmol Vis Sci 53 (2012), 2030–2037.
7. 7 Hempstead, BL, Commentary: regulating proNGF action: multiple targets for therapeutic intervention. Neurotox Res 16 (2009), 255–260.
8. 8 Casaccia-Bonnefil, P, Carter, BD, Dobrowsky, RT, Chao, MV, Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383 (1996), 716–719.
9. 9 Allard, S, Leon, WC, Pakavathkumar, P, Bruno, MA, Ribeiro-da-Silva, A, Cuello, AC, Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J Neurosci 32 (2012), 2002–2012.
10. 10 Iulita, MF, Do Carmo, S, Ower, AK, Fortress, AM, Aguilar, LF, Hanna, M, et al. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain 137:Pt 3 (2014), 860–872.
11. 11 Santos, AM, López-Sánchez, N, Martín-Oliva, D, de la Villa, P, Cuadros, MA, Frade, JM, Sortilin participates in light-dependent photoreceptor degeneration in vivo. PLoS One, 7, 2012, e36243.
12. 12 Lebrun-Julien, F, Bertrand, MJ, De Backer, O, Stellwagen, D, Morales, CR, Di Polo, A, et al. ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci USA 107 (2010), 3817–3822.
13. 13 Ali, TK, Matragoon, S, Pillai, BA, Liou, GI, El-Remessy, AB, Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57 (2008), 889–898.
14. 14 Al-Gayyar, MM, Abdelsaid, MA, Matragoon, S, Pillai, BA, El-Remessy, AB, Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164 (2011), 170–180.
15. 15 Ali, TK, Al-Gayyar, MM, Matragoon, S, Pillai, BA, Abdelsaid, MA, Nussbaum, JJ, et al. Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury. Diabetologia 54 (2011), 657–668.
16. 16 Al-Gayyar, MM, Mysona, BA, Matragoon, S, Abdelsaid, MA, El-Azab, MF, Shanab, AY, et al. Diabetes and overexpression of proNGF cause retinal neurodegeneration via activation of RhoA pathway. PLoS One, 8, 2013, e54692.
17. 17 Mysona, BA, Al-Gayyar, MM, Matragoon, S, Abdelsaid, MA, El-Azab, MF, Saragovi, HU, et al. Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats. Diabetologia 56 (2013), 2329–2339.
18. 18 Matragoon, S, Al-Gayyar, MM, Mysona, BA, Abdelsaid, MA, Pillai, BA, Neet, KE, et al. Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration. Mol Vis 18 (2012), 2993–3003.
19. 19 Zampieri, N, Xu, CF, Neubert, TA, Chao, MV, Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. J Biol Chem 280 (2005), 14563–14571.
20. 20 Fortini, ME, Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol 3 (2002), 673–684.
21. 21 Linggi, MS, Burke, TL, Williams, BB, Harrington, A, Kraemer, R, Hempstead, BL, et al. Neurotrophin receptor interacting factor (NRIF) is an essential mediator of apoptotic signaling by the p75 neurotrophin receptor. J Biol Chem 280 (2005), 13801–13808.
22. 22 Salehi, AH, Roux, PP, Kubu, CJ, Zeindler, C, Bhakar, A, Tannis, LL, et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27 (2000), 279–288.
23. 23 Kenchappa, RS, Zampieri, N, Chao, MV, Barker, PA, Teng, HK, Hempstead, BL, et al. Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 50 (2006), 219–232.
24. 24 Casademunt, E, Carter, BD, Benzel, I, Frade, JM, Dechant, G, Barde, YA, The zinc finger protein NRIF interacts with the neurotrophin receptor p75(NTR) and participates in programmed cell death. EMBO J 18 (1999), 6050–6061.
25. 25 Zheng, L, Gong, B, Hatala, DA, Kern, TS, Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 48 (2007), 361–367.
26. 26 Skeldal, S, Matusica, D, Nykjaer, A, Coulson, EJ, Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). Bioessays 33 (2011), 614–625.
27. 27 LeSauteur, L, Wei, L, Gibbs, BF, Saragovi, HU, Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270 (1995), 6564–6569.
28. 28 Kim, H, Li, Q, Hempstead, BL, Madri, JA, Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 279 (2004), 33538–33546.
29. 29 Caporali, A, Pani, E, Horrevoets, AJ, Kraenkel, N, Oikawa, A, Sala-Newby, GB, et al. Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res 103 (2008), e15–e26.
30. 30 Siao, CJ, Lorentz, CU, Kermani, P, Marinic, T, Carter, J, McGrath, K, et al. ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. J Exp Med 209 (2012), 2291–2305.
31. 31 Al-Gayyar, MM, Matragoon, S, Pillai, BA, Ali, TK, Abdelsaid, MA, El-Remessy, AB, Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected]. Diabetologia 54 (2011), 669–680.
32. 32 Ichijo, H, Nishida, E, Irie, K, ten Dijke, P, Saitoh, M, Moriguchi, T, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997), 90–94.
33. 33 Bamji, SX, Majdan, M, Pozniak, CD, Belliveau, DJ, Aloyz, R, Kohn, J, et al. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140 (1998), 911–923.
34. 34 Beattie, MS, Harrington, AW, Lee, R, Kim, JY, Boyce, SL, Longo, FM, et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36 (2002), 375–386.
35. 35 Bhakar, AL, Howell, JL, Paul, CE, Salehi, AH, Becker, EB, Said, F, et al. Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J Neurosci 23 (2003), 11373–11381.
36. 36 Barde, YA, Death of injured neurons caused by the precursor of nerve growth factor. Proc Natl Acad Sci USA 101 (2004), 5703–5704.
37. 37 Teng, KK, Felice, S, Kim, T, Hempstead, BL, Understanding proneurotrophin actions: recent advances and challenges. Dev Neurobiol 70 (2010), 350–359.
38. 38 Geetha, T, Kenchappa, RS, Wooten, MW, Carter, BD, TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J 24 (2005), 3859–3868.
39. 39 Jadhav, TS, Wooten, MW, Wooten, MC, Mining the TRAF6/p62 interactome for a selective ubiquitination motif. BMC Proc, 5 (suppl. 2), 2011, S4.
40. 40 Volosin, M, Trotter, C, Cragnolini, A, Kenchappa, RS, Light, M, Hempstead, BL, et al. Induction of proneurotrophins and activation of p75NTR-mediated apoptosis via neurotrophin receptor-interacting factor in hippocampal neurons after seizures. J Neurosci 28 (2008), 9870–9879.
41. 41 Hammes, HP, Federoff, HJ, Brownlee, M, Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1 (1995), 527–534.
42. 42 Colafrancesco, V, Coassin, M, Rossi, S, Aloe, L, Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration. Ann Ist Super Sanita 47 (2011), 284–289.
43. 43 Mantelli, F, Lambiase, A, Colafrancesco, V, Rocco, ML, Macchi, I, Aloe, L, NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes. Eur J Ophthalmol 24 (2014), 247–253.
44. 44 Al-Gayyar, MM, Abdelsaid, MA, Matragoon, S, Pillai, BA, El-Remessy, AB, Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes. Am J Pathol 177 (2010), 1187–1197.
45. 45 Mohamed, IN, Hafez, SS, Fairaq, A, Ergul, A, Imig, JD, El-Remessy, AB, Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia 57 (2014), 413–423.
46. 46 Negishi, M, Lu, D, Zhang, YQ, Sawada, Y, Sasaki, T, Kayo, T, et al. Upregulatory expression of furin and transforming growth factor-beta by fluid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 21 (2001), 785–790.
47. 47 el-Remessy, AB, Bartoli, M, Platt, DH, Fulton, D, Caldwell, RB, Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:Pt 1 (2005), 243–252.
48. 48 Shanab, AY, Nakazawa, T, Ryu, M, Tanaka, Y, Himori, N, Taguchi, K, et al. Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor. Neurobiol Dis 48 (2012), 556–567.